Glucose-Responsive Nanoparticles for Targeted Insulin Delivery in the Treatment of Diabetes. Journal of Carcinogenesis, [S. l.], v. 24, n. 4s, p. 914–927, 2025. DOI: 10.64149/J.Carcinog.24.4s.914-927. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/647. Acesso em: 26 dec. 2025.